Episode Details
Back to EpisodesResMed Inc. (RMD): An Asymmetric Risk Analysis of the Sleep-Disordered Breathing Monopoly
Published 5 months ago
Description
Slide Deck 1. Executive Summary: The Quality Trap ResMed Inc. (RMD) presents one of the most complex investment paradoxes in the current medical technology landscape. On the surface, the company appears to be a quintessential “compounder”—a business with a dominant market share (exceeding 80% in key regions), a wide competitive moat forged by a digital […]